# EDGAR Filing Document

**Accession Number:** 0000320351
**File Stem:** 0000035402-25-001461
**Filing Date:** 2025-10
**Character Count:** 21787
**Document Hash:** 48c9e29dd548a5746dc10b4c4ff9614c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000035402-25-001461.hdr.sgml**: 20251028

**ACCESSION NUMBER**: 0000035402-25-001461

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250831

**FILED AS OF DATE**: 20251028

**DATE AS OF CHANGE**: 20251028

**PERIOD START**: 20260228

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FIDELITY SELECT PORTFOLIOS
- **CENTRAL INDEX KEY:** 0000320351

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0228

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-03114
- **FILM NUMBER:** 251424519

**BUSINESS ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 617-563-7000

**MAIL ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

## Series and Classes Contracts Data

### Pharmaceuticals Portfolio (Series ID: S000007481)

| Class ID   | Class Name                | Ticker Symbol   |
|:---|:---|:---|
| C000020455 | Pharmaceuticals Portfolio | FPHAX           |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Fidelity Select Portfolios

- **b. Investment Company Act file number:** 811-03114

- **c. CIK number of Registrant:** 0000320351

- **d. LEI of Registrant:** Z57125JG1LHEQKDYS630

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 245 Summer Street

  - **City:** Boston

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02210

  - **Telephone number:** 1-800-FIDELITY

**Item A.2. Information about the Series.**

- **a. Name of Series:** Select Pharmaceuticals Portfolio

- **b. EDGAR series identifier (if any):** S000007481

- **c. LEI of Series:** MN21BN6DBQP38HPMPO32

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-02-28

- **b. Date as of which information is reported:** 2025-08-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $1093526466.47

**Total Liabilities:** $13821903.46

**Net Assets:** $1079704563.01

**Cash Not Reported:** $347064.61

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000020455 | 2.33%                | -3.14%               | 6.60%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $5965621.99              | $19819980.76                               |
| Month 2  | $-2750946.60             | $-29577357.91                              |
| Month 3  | $-7691859.76             | $72486798.46                               |

### Schedule of Portfolio Investments

| Name                                   | Title                                                 | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| EVOZYNE INC                            | EVOZYNE INC CPIK 6% 09/13/2028 P/P                    | CUSIP: N/A<br>LEI: N/A                        | Long             | DBT              | CORP              | US        |    978945 | PA      | $1113353.83   | 0.10%             | 2028-09-13      | Fixed         | 0.06%                 | Yes           |                  3 | On Loan: No      |
| AXSOME THERAPEUTICS INC                | AXSOME THERAPEUTICS INC                               | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     48900 | NS      | $5930592.00   | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| NOVO-NORDISK AS                        | NOVO-NORDISK AS CL B ADR                              | CUSIP: 670100205<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |   2063000 | NS      | $116476980.00 | 10.79%            |  |  |  | No            |                  1 | On Loan: No      |
| CASTLE CREEK BIOSCIENCES INC           | CASTLE CREEK BIOSCIENCES INC SER D-1 PC PP            | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |      6308 | NS      | $1321526.00   | 0.12%             |  |  |  | Yes           |                  3 | On Loan: No      |
| CRINETICS PHARMACEUTICALS INC          | CRINETICS PHARMACEUTICALS INC                         | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |    122800 | NS      | $3805572.00   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| INTELLIA THERAPEUTICS INC              | INTELLIA THERAPEUTICS INC                             | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |    472500 | NS      | $5365237.50   | 0.50%             |  |  |  | No            |                  1 | On Loan: —       |
| CASTLE CREEK BIOSCIENCES INC           | CASTLE CREEK BIOSCIENCES INC SER C PC PERP PP         | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |       200 | NS      | $46866.00     | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| PARAGON BIOSCIENCES EMALEX CAPITAL INC | PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-2 PC PP  | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |     22477 | NS      | $276467.10    | 0.03%             |  |  |  | Yes           |                  3 | On Loan: No      |
| DISC MEDICINE INC                      | DISC MEDICINE INC                                     | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    118900 | NS      | $7091790.50   | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCK and CO INC                       | MERCK and CO INC NEW                                  | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    631436 | NS      | $53116396.32  | 4.92%             |  |  |  | No            |                  1 | On Loan: No      |
| LEAP THERAPEUTICS INC                  | LEAP THERAPEUTICS INC WT                              | CUSIP: N/A<br>LEI: 549300T31SMMJ2DDLI13       | Long             | EC               | CORP              | US        |     60600 | NS      | $0.61         | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| PARAGON BIOSCIENCES EMALEX CAPITAL INC | PARAGON BIOSCIENCES EMALEX CAPITAL INC SER C PC PP    | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |    158879 | NS      | $2046361.52   | 0.19%             |  |  |  | Yes           |                  3 | On Loan: No      |
| ROYALTY PHARMA PLC                     | ROYALTY PHARMA PLC                                    | CUSIP: N/A<br>LEI: 549300FGFN7VOK8BZR03       | Long             | EC               | CORP              | GB        |   1160000 | NS      | $41736800.00  | 3.87%             |  |  |  | No            |                  1 | On Loan: No      |
| EDGEWISE THERAPEUTICS INC              | EDGEWISE THERAPEUTICS INC                             | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     83600 | NS      | $1199660.00   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| AGOMAB THERAPEUTICS SA                 | AGOMAB THERAPEUTICS SA ANTI-DILUTION WT PP 11/04/2034 | CUSIP: N/A<br>LEI: 894500APP6UE5N4PKJ68       | Long             | EC               | CORP              | BE        |        10 | NS      | $0.00         | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| ULTRAGENYX PHARMACEUTICAL INC          | ULTRAGENYX PHARMA INC                                 | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |    254500 | NS      | $7624820.00   | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| AGOMAB THERAPEUTICS SA                 | AGOMAB THERAPEUTICS SA SER C PC PP                    | CUSIP: N/A<br>LEI: 894500APP6UE5N4PKJ68       | Long             | EP               | CORP              | BE        |      7729 | NS      | $2112700.01   | 0.20%             |  |  |  | Yes           |                  3 | On Loan: No      |
| MEDAVAIL HOLDINGS INC                  | MEDAVAIL HOLDINGS INC PIPE                            | CUSIP: N/A<br>LEI: 549300ZNQGSJ2V3ZB668       | Long             | EC               | CORP              | US        |        66 | NS      | $0.01         | 0.00%             |  |  |  | Yes           |                  1 | On Loan: No      |
| UNIQURE N.V.                           | UNIQURE N.V.                                          | CUSIP: N/A<br>LEI: 724500RPCTZLFYJZ3S98       | Long             | EC               | CORP              | NL        |    358100 | NS      | $5847773.00   | 0.54%             |  |  |  | No            |                  1 | On Loan: —       |
| AVIDITY BIOSCIENCES INC                | AVIDITY BIOSCIENCES                                   | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    793500 | NS      | $36961230.00  | 3.42%             |  |  |  | No            |                  1 | On Loan: —       |
| BIONTECH SE                            | BIONTECH SE ADR                                       | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |    104553 | NS      | $10455300.00  | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| PARAGON BIOSCIENCES EMALEX CAPITAL INC | PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-3 PC PP  | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |      4581 | NS      | $63538.47     | 0.01%             |  |  |  | Yes           |                  3 | On Loan: No      |
| EVOZYNE INC                            | EVOZYNE INC SER B PC PP                               | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |     56643 | NS      | $932910.21    | 0.09%             |  |  |  | Yes           |                  3 | On Loan: No      |
| MODERNA INC                            | MODERNA INC                                           | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |    417600 | NS      | $10059984.00  | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| ASTRAZENECA PLC                        | ASTRAZENECA PLC SPONS ADR                             | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |   1460800 | NS      | $116717920.00 | 10.81%            |  |  |  | No            |                  1 | On Loan: No      |
| ELI LILLY and CO                       | ELI LILLY and CO                                      | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    397261 | NS      | $291025463.38 | 26.95%            |  |  |  | No            |                  1 | On Loan: No      |
| ELANCO ANIMAL HEALTH INC               | ELANCO ANIMAL HEALTH INC                              | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |   2531100 | NS      | $46445685.00  | 4.30%             |  |  |  | No            |                  1 | On Loan: No      |
| SUMMIT THERAPEUTICS INC                | SUMMIT THERAPEUTICS INC                               | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     73517 | NS      | $1742352.90   | 0.16%             |  |  |  | No            |                  1 | On Loan: —       |
| CASTLE CREEK BIOSCIENCES INC           | CASTLE CREEK BIOSCIENCES INC SER D-2 PC PP            | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |        85 | NS      | $15776.00     | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| ASCENDIS PHARMA A/S                    | ASCENDIS PHARMA AS SPON ADR                           | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |     36100 | NS      | $7013147.00   | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| LEGEND BIOTECH CORP                    | LEGEND BIOTECH CORP SPON ADR                          | CUSIP: 52490G102<br>LEI: 254900EIUFZTW136H859 | Long             | EC               | CORP              | KY        |    832700 | NS      | $28919671.00  | 2.68%             |  |  |  | No            |                  1 | On Loan: No      |
| AGOMAB THERAPEUTICS SA                 | AGOMAB THERAPEUTICS SA SER D PC PP                    | CUSIP: N/A<br>LEI: 894500APP6UE5N4PKJ68       | Long             | EP               | CORP              | BE        |      7649 | NS      | $2155440.88   | 0.20%             |  |  |  | Yes           |                  3 | On Loan: No      |
| METSERA INC                            | METSERA INC                                           | CUSIP: 59267L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    278676 | NS      | $9834476.04   | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| VIR BIOTECHNOLOGY INC                  | VIR BIOTECHNOLOGY INC                                 | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    280800 | NS      | $1387152.00   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC THERAPEUTICS INC                   | PTC THERAPEUTICS INC                                  | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |    150800 | NS      | $7438964.00   | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                                 | UCB SA                                                | CUSIP: N/A<br>LEI: 2138008J191VLSGY5A09       | Long             | EC               | CORP              | BE        |    234100 | NS      | $54733637.11  | 5.07%             |  |  |  | No            |                  1 | On Loan: No      |
| ARRIVENT BIOPHARMA INC                 | ARRIVENT BIOPHARMA INC                                | CUSIP: 04272N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    107000 | NS      | $2045840.00   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK PLC                                | GSK PLC SPONS ADR                                     | CUSIP: 37733W204<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |   1342860 | NS      | $53271256.20  | 4.93%             |  |  |  | No            |                  1 | On Loan: No      |
| HARMONY BIOSCIENCES HOLDINGS INC       | HARMONY BIOSCIENCES HOLDINGS INC                      | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     93877 | NS      | $3463122.53   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| FINANCIERE DE TUBIZE SA                | FINANCIERE DE TUBIZE SA                               | CUSIP: N/A<br>LEI: 549300I1MGC0OK6W8828       | Long             | EC               | CORP              | BE        |    141200 | NS      | $26397342.90  | 2.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Fidelity Revere Street Trust           | Fidelity Securities Lending Cash Central Fund         | CUSIP: 31635A303<br>LEI: 549300BDV45LJNXBZC55 | Long             | STIV             | RF                | US        |  12994526 | NS      | $12995825.64  | 1.20%             |  |  |  | No            |                  1 | On Loan: No      |
| EVOZYNE INC                            | EVOZYNE INC SER A PC PP                               | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |      5900 | NS      | $93397.00     | 0.01%             |  |  |  | Yes           |                  3 | On Loan: No      |
| BEAM THERAPEUTICS INC                  | BEAM THERAPEUTICS INC                                 | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    239700 | NS      | $3921492.00   | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| XENON PHARMACEUTICALS INC              | XENON PHARMACEUTICALS INC                             | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |    284300 | NS      | $11005253.00  | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| AGOMAB THERAPEUTICS SA                 | AGOMAB THERAPEUTICS SA ANTI-DILUTION WT PP 10/10/2033 | CUSIP: N/A<br>LEI: 894500APP6UE5N4PKJ68       | Long             | EC               | CORP              | BE        |        10 | NS      | $0.00         | 0.00%             |  |  |  | Yes           |                  3 | On Loan: No      |
| OCULAR THERAPEUTIX INC                 | OCULAR THERAPEUTIX INC                                | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |   1306417 | NS      | $15951351.57  | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| INSMED INC                             | INSMED INC                                            | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     48200 | NS      | $6560020.00   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| GILEAD SCIENCES INC                    | GILEAD SCIENCES INC                                   | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    416900 | NS      | $47097193.00  | 4.36%             |  |  |  | No            |                  1 | On Loan: No      |
| PARAGON BIOSCIENCES EMALEX CAPITAL INC | PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-1 PC PP  | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |     15977 | NS      | $206422.84    | 0.02%             |  |  |  | Yes           |                  3 | On Loan: No      |
| VIKING THERAPEUTICS INC                | VIKING THERAPEUTICS INC                               | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |     65000 | NS      | $1758250.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: —       |
| MERUS NV                               | MERUS B.V.                                            | CUSIP: N/A<br>LEI: 549300W8GPUWU8QNU293       | Long             | EC               | CORP              | NL        |     90400 | NS      | $5951936.00   | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| JAZZ PHARMACEUTICALS PLC               | JAZZ PHARMA PLC                                       | CUSIP: N/A<br>LEI: 635400GAUMJCLEZRRV50       | Long             | EC               | CORP              | IE        |     57100 | NS      | $7294525.00   | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| ARCUS BIOSCIENCES INC                  | ARCUS BIOSCIENCES INC                                 | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    853517 | NS      | $9038745.03   | 0.84%             |  |  |  | No            |                  1 | On Loan: —       |

### Signature

**Date Signed:** 2025-09-30

**Name of Applicant:** Stacie M. Smith

**Signature:** Stacie M. Smith

**Name of Signer:** Stacie M. Smith

**Title:** President and Treasurer